How does vedolizumab actually calm down my gut's immune system?
Vedolizumab blocks integrin receptors on immune cells, preventing them from traveling to your gut and attacking the intestinal lining. 2024 AGA data shows 60% of patients reach clinical remission within 6 weeks of starting treatment [1].
Your gut has special immune cells that normally protect you from bad bacteria. In ulcerative colitis and Crohn's disease, these cells go haywire and attack your own intestines instead. Vedolizumab works like a bouncer at a nightclub—it blocks the 'door' (integrin receptors) that lets immune cells enter your gut tissue. The result: fewer attacks, less inflammation, and healing [2].
Think of integrin as a lock-and-key system. Your immune cells have keys (integrins) that fit into locks (receptors) on your gut's blood vessels. Vedolizumab is the master key that jams the lock, so immune cells can't get through. This happens only in your gut, not your whole body, which is why vedolizumab is gentler than older biologic drugs [4].
Most patients feel better within 2–4 weeks, but full healing takes 6–10 weeks. You'll need three IV infusions (weeks 0, 2, and 6) to build up enough drug in your system. After that, you get maintenance doses every 8 weeks by IV or every 2 weeks by self-injection at home [9].
Ask your gastroenterologist: 'When should I expect to feel better, and what does remission look like for me?' Keep a symptom diary (bowel movements, blood, pain) for 2 weeks before your first dose so you can measure real improvement.